Viral Genetic Diversity and Its Potential Contributions to the Development and Progression of Neonatal Herpes Simplex Virus (HSV) Disease
- 25 Downloads
Purpose of Review
Neonatal infection by herpes simplex virus (HSV) 1 or 2 presents a devastating burden to new parents due to the unpredictability of severe clinical outcomes as well as the potential for lifelong viral reactivation. While just under half of neonatal HSV infections have mild clinical impacts akin to the skin lesions observed in adults, the other half of these infants experience viral spread throughout the body (disseminated infection) and/or the brain (central nervous system infection).
Here we summarize current data on clinical diagnostic measures, antiviral therapy, and known aspects of human host biology that contribute to the distinct neonatal outcomes of HSV infection.
We then explore recent new data on how viral genetic diversity between infections may impact clinical outcomes. Further research will be critical to build upon these early findings and to provide statistical power to our ability to discern and/or predict the potential clinical course of a given neonatal infection.
KeywordsNeonatal Herpes simplex virus Human herpesvirus 1 Human herpesvirus 2 Comparative genomics Encephalitis
We thank the members of the Szpara and Weitzman labs for helpful discussions.
This research was supported by NIAID grant 1R21AI140443 (MLS) and NINDS grant 1K08NS109332 (LNA), with additional support from the following: startup funds from the Pennsylvania State University (MLS) and a CURE grant from the Pennsylvania (PA) Department of Health (MLS). The PA Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights
This article does not contain any studies with human or animal subjects performed by either of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.• Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Newman LM, et al. First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health. 2017;5(3):e300–9. This study provides a recent statistical evaluation of the global burden of neonatal HSV. The authors note that these estimates are subject to under-reporting and unrecognized diagnoses of neonatal HSV, especially in areas with a high incidence of genital HSV.PubMedPubMedCentralCrossRefGoogle Scholar
- 3.Looker KJ, Magaret AS, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global estimates. This study analyzed over 58,000 live births to detect HSV shedding at the of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10(1):e114989.PubMedPubMedCentralCrossRefGoogle Scholar
- 4.•• Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. Jama. 2003;289(2):203–9 Time of delivery of these just over 200 were HSV-positive. Statistics on transmission risk derived from this landmark study form the basis of current medical practice for the care of HSV-positive mothers and their neonates during childbirth.PubMedCrossRefPubMedCentralGoogle Scholar
- 8.• Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230–8. This is one of three related clinical trials that form the basis of current therapeutic approaches for the treatment and ongoing case-management of HSV-infected neonates.PubMedCrossRefPubMedCentralGoogle Scholar
- 10.• Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365(14):1284–92. This is the most recent of three related clinical trials that form the basis of current therapeutic approaches for the treatment and ongoing case-management of HSV-infected neonates. PubMedCrossRefPubMedCentralGoogle Scholar
- 13.• Shipley MM, Renner DW, Pandey U, Ford B, Bloom DC, Grose C, et al. Personalized viral genomic investigation of herpes simplex virus 1 perinatal viremic transmission with dual fatality. Mol Case Stud. 2019;mcs.a004382. This recent study uses oligonucleotide-baits to enrich HSV genomes without culturing, from diagnostic samples of an unusual case of maternal-neonatal transmission. These data reveal that the majority of viral genetic diversity in a maternal viremic infection is transferred to the neonate, and that new viral genetic diversity can arise quickly in the neonate.Google Scholar
- 14.Muller WJ, Zheng X. Laboratory diagnosis of neonatal herpes simplex virus infections. J Clin Microbiol. 2019;57(5):e01460-18.Google Scholar
- 15.• Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med. 1991;324(7):444–9. This is one of three related clinical trials that form the basis of current therapeutic approaches for the treatment and ongoing case-management of HSV-infected neonates.PubMedCrossRefPubMedCentralGoogle Scholar
- 17.•• Jiang Y, Patel CD, Manivanh R, North B, Backes IM, Posner DA, et al. Maternal antiviral immunoglobulin accumulates in neural tissue of neonates to prevent HSV neurological disease. mBio. 2017 6;8(4):e00678-17. This key study demonstrates not only the presence of maternal antibody in neonatal nervous system tissue, but also a protective role for the neonate in this transfer of maternal immunity.Google Scholar
- 19.• Casrouge A, Zhang S-Y, Eidenschenk C, Jouanguy E, Puel A, Yang K, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 2006;314:6. This is one in a series of publications from Casanova and colleagues that delineate host genetic contributions to HSV encephalitis outside of the neonatal period. PubMedCrossRefGoogle Scholar
- 21.Pérez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, et al. Human TRAF3 adaptor molecule deficiency leads to impaired toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 2010 Sep;33(3):400–11.PubMedCrossRefPubMedCentralGoogle Scholar
- 32.Sakaoka H, Kurita K, Iida Y, Takada S, Umene K, Kim YT, et al. Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol. 1994;75(3):513–27.PubMedCrossRefPubMedCentralGoogle Scholar
- 36.• Szpara ML, Gatherer D, Ochoa A, Greenbaum B, Dolan A, Bowden RJ, et al. Evolution and diversity in human herpes simplex virus genomes. J Virol. 2014;88(2):1209–27. This study provides a comprehensive comparative genomics assessment of the sequence diversity of 26 strains of HSV-1, and it explores the impacts of these viral genetic differences at the level of genomes, genes, proteins, and non-coding features.PubMedCrossRefPubMedCentralGoogle Scholar
- 37.Pandey U, Renner DW, Thompson RL, Szpara ML, Sawtell NM. Inferred father-to-son transmission of herpes simplex virus results in near-perfect preservation of viral genome identity and in vivo phenotypes. Sci Rep. 2017;7(1).Google Scholar
- 38.Greninger AL, Roychoudhury P, Xie H, Casto A, Cent A, Pepper G, et al. Ultrasensitive capture of human herpes simplex virus genomes directly from clinical samples reveals extraordinarily limited evolution in cell culture. mSphere. 2018;3(3):e00283–18.Google Scholar
- 41.Minaya MA, Jensen TL, Goll JB, Korom M, Datla SH, Belshe RB, et al. Molecular evolution of herpes simplex virus 2 complete genomes: comparison between primary and recurrent infections. J Virol. 2017 ;91(23). :e00942–17.Google Scholar
- 42.Johnston C, Magaret A, Roychoudhury P, Greninger AL, Reeves D, Schiffer J, et al. Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: a nested cross-sectional viral genotyping study. PLoS Med. 2017;14(12):e1002475.PubMedPubMedCentralCrossRefGoogle Scholar
- 43.•• Akhtar LN, Bowen CD, Renner DW, Pandey U, Della Fera AN, Kimberlin DW, et al. Genotypic and phenotypic diversity of herpes simplex virus 2 within the infected neonatal population. mSphere. 2019;4(1):e00590-18. This study by the authors provides the impetus for this review. It reveals for the first time the breadth neonatal of viral genetic diversity, and phenotypic diversity in terms of cell-to-cell spread phenotypes, using HSV-2 cultures from the initial diagnoses of newly-infected neonates.Google Scholar
- 45.Koelle DM, Norberg P, Fitzgibbon MP, Russell RM, Greninger AL, Huang M-L, et al. Worldwide circulation of HSV-2 × HSV-1 recombinant strains. Sci Rep. 2017;7(1): 44084.Google Scholar
- 47.Casto AM, Roychoudhury P, Xie H, Selke S, Perchetti GA, Wofford H, et al. Large, stable, contemporary interspecies recombination events in circulating human herpes simplex viruses. J Infect Dis. 2019; jiz199. https://doi.org/10.1093/infdis/jiz199.
- 48.Kimberlin D. Identification of herpes simplex virus (HSV) shedding in the female genital tract of pregnant and nonpregnant women by GeneXpert PCR, routine PCR, and culture. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2013. Available from: https://clinicaltrials.gov/ct2/show/NCT01878383.
- 50.Otto WR, Myers AL, LaRussa B, Kimberlin DW, Jackson MA. Clinical markers and outcomes of neonates with herpes simplex virus deoxyribonucleic acid persistence in cerebrospinal fluid in disseminated and central nervous system infection. J Pediatric Infect Dis Soc. 2018;7(2):e30–3.PubMedCrossRefPubMedCentralGoogle Scholar
- 52.Bower JR, Mao H, Durishin C, Rozenbom E, Detwiler M, Rempinski D, et al. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J Virol. 1999;73:11.Google Scholar
- 53.• Renzette N, Gibson L, Bhattacharjee B, Fisher D, Schleiss MR, Jensen JD, et al. Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet. 2013;9(9):1–14. This is one example in a series of studies on congenital infections caused by the betaherpesvirus, human cytomegalovirus (HCMV). While the cell types infected by HCMV and its manner of spread are quite distinct from those of HSV, these studies have influenced ongoing comparative genomics analyses of this and other herpesviruses.PubMedPubMedCentralCrossRefGoogle Scholar
- 55.Hage E, Wilkie GS, Linnenweber-Held S, Dhingra A, Suárez NM, Schmidt JJ, et al. Characterization of human Cytomegalovirus genome diversity in immunocompromised hosts by whole-genome sequencing directly from clinical specimens. J Infect Dis. 2017;215(11):1673–83.PubMedCrossRefPubMedCentralGoogle Scholar